Pancreatic Ductal Adenocarcinoma, β-blockers, and Antihistamines: A Clinical Trial Is Needed
Jillian G. Baker(Nottingham University Hospitals NHS Trust), Paul A. Insel(UC San Diego Health System), Erica K. Sloan(Monash University), Peter J. McCormick(Queen Mary University of London), Kevin D. G. Pfleger(Harry Perkins Institute of Medical Research), Cristina Salmerón(University of California San Diego)
Cited by 4
Related Papers
Structure of a β1-adrenergic G-protein-coupled receptor
|Nature|2008|1.3k
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor
|Nature|2011|623
The selectivity of β‐adrenoceptor agonists at human β<sub>1</sub>‐, β<sub>2</sub>‐ and β<sub>3</sub>‐adrenoceptors
|British Journal of Pharmacology|2010|586
The selectivity of <i>β</i>‐adrenoceptor antagonists at the human <i>β</i>1, <i>β</i>2 and <i>β</i>3 adrenoceptors
|British Journal of Pharmacology|2005|535
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
|British Journal of Pharmacology|2023|390